Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.

Evans M, Khunti K, Mamdani M, Galbo-Jørgensen CB, Gundgaard J, Bøgelund M, Harris S.

Health Qual Life Outcomes. 2013 Jun 3;11:90. doi: 10.1186/1477-7525-11-90.

2.

The effect of hypoglycemia on health-related quality of life: Canadian results from a multinational time trade-off survey.

Harris S, Mamdani M, Galbo-Jørgensen CB, Bøgelund M, Gundgaard J, Groleau D.

Can J Diabetes. 2014 Feb;38(1):45-52. doi: 10.1016/j.jcjd.2013.09.001.

3.

Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries.

Lauridsen JT, Lønborg J, Gundgaard J, Jensen HH.

Qual Life Res. 2014 Nov;23(9):2645-50. doi: 10.1007/s11136-014-0712-x. Epub 2014 May 17.

PMID:
24838908
4.

Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom.

Levy AR, Christensen TL, Johnson JA.

Health Qual Life Outcomes. 2008 Sep 29;6:73. doi: 10.1186/1477-7525-6-73.

5.

A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function.

Brod M, Wolden M, Christensen T, Bushnell DM.

Diabetes Obes Metab. 2013 Jun;15(6):546-57. doi: 10.1111/dom.12070. Epub 2013 Feb 25.

6.

Self-reported non-severe hypoglycaemic events in Europe.

Östenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Markert Jensen M, Pedersen-Bjergaard U.

Diabet Med. 2014 Jan;31(1):92-101. doi: 10.1111/dme.12261. Epub 2013 Jul 26.

7.

Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects.

Frier BM, Jensen MM, Chubb BD.

Diabet Med. 2016 Aug;33(8):1125-32. doi: 10.1111/dme.12878. Epub 2015 Sep 7.

8.

The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys.

Fulcher G, Singer J, Castañeda R, Fraige Filho F, Maffei L, Snyman J, Brod M.

J Med Econ. 2014 Oct;17(10):751-61. doi: 10.3111/13696998.2014.946992. Epub 2014 Aug 5.

PMID:
25061766
9.

Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.

Kulzer B, Seitz L, Kern W.

Exp Clin Endocrinol Diabetes. 2014 Mar;122(3):167-72. doi: 10.1055/s-0033-1363688. Epub 2014 Mar 18.

PMID:
24643694
10.

Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.

Peene B, D'Hooge D, Vandebrouck T, Mathieu C.

Acta Clin Belg. 2014 Dec;69(6):439-45. doi: 10.1179/2295333714Y.0000000050. Epub 2014 Sep 12.

PMID:
25212241
11.

Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study.

Simon D, de Pablos-Velasco P, Parhofer KG, Gönder-Frederick L, Duprat Lomon I, Vandenberghe H, Eschwège E, Bradley C.

Diabetes Metab. 2015 Dec;41(6):470-9. doi: 10.1016/j.diabet.2015.08.007. Epub 2015 Oct 9.

PMID:
26455870
12.

Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.

Khunti K, Alsifri S, Aronson R, Cigrovski Berković M, Enters-Weijnen C, Forsén T, Galstyan G, Geelhoed-Duijvestijn P, Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A; HAT Investigator Group.

Diabetes Res Clin Pract. 2017 Aug;130:121-129. doi: 10.1016/j.diabres.2017.05.004. Epub 2017 May 12.

13.

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.

Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP; DARTS/MEMO Collaboration.

Diabet Med. 2005 Jun;22(6):749-55.

PMID:
15910627
14.

Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study.

Ridderstråle M, Evans LM, Jensen HH, Bøgelund M, Jensen MM, Ericsson Å, Jendle J.

Health Qual Life Outcomes. 2016 Jan 22;14:13. doi: 10.1186/s12955-016-0411-0.

15.

Utilities for treatment-related adverse events in type 2 diabetes.

Shingler S, Fordham B, Evans M, Schroeder M, Thompson G, Dewilde S, Lloyd AJ.

J Med Econ. 2015 Jan;18(1):45-55. doi: 10.3111/13696998.2014.971158. Epub 2014 Oct 10.

PMID:
25266815
16.

Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes.

Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ.

Curr Med Res Opin. 2005 Sep;21(9):1477-83.

PMID:
16197667
17.

Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro.

Bastyr EJ 3rd, Huang Y, Brunelle RL, Vignati L, Cox DJ, Kotsanos JG.

Diabetes Obes Metab. 2000 Jan;2(1):39-46.

PMID:
11220353
18.

Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey.

Evans M, Jensen HH, Bøgelund M, Gundgaard J, Chubb B, Khunti K.

J Med Econ. 2013 Nov;16(11):1357-65. doi: 10.3111/13696998.2013.846262. Epub 2013 Oct 11.

PMID:
24111563
19.

The relationships among fear of hypoglycaemia, diabetes-related quality of life and psychological well-being in Norwegian adults with Type 1 diabetes.

Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Wahl AK, Rokne B.

Diabetes Res Clin Pract. 2017 Feb;124:11-19. doi: 10.1016/j.diabres.2016.12.018. Epub 2016 Dec 27.

PMID:
28081448
20.

Clinical characterisation of severe hypoglycaemia--a prospective population-based study.

Holstein A, Plaschke A, Egberts EH.

Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):364-9.

PMID:
14520604

Supplemental Content

Support Center